MPO and inflammatory bowel disease: Our evaluation of diagnostic performance only considered hs-CRP and fcalpro, without considering more recently proposed markers for IBD (eg, myeloperoxidase and different lipid species).17,35 We cannot exclude the possibility of false negatives resulting from immune exhaustion in some IBD patients or false positives due to cross-reactivity with other integrin family proteins.